WAP
BSX icon

Wealthcare Advisory Partners’s Boston Scientific BSX Stock Holding History

Wealthcare Advisory Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,321
Closed -$208K – 1099
2026
Q1 		$208K Sell
3,321
-528
-14% -$42.2K ﹤0.01% 1013
2025
Q4 		$367K Buy
3,849
+243
+7% +$23.8K 0.01% 798
2025
Q3 		$352K Sell
3,606
-127
-3% -$13.2K 0.01% 788
2025
Q2 		$401K Buy
3,733
+58
+2% +$5.87K 0.01% 702
2025
Q1 		$371K Buy
3,675
+754
+26% +$75.9K 0.01% 671
2024
Q4 		$261K Buy
2,921
+29
+1% +$2.55K 0.01% 759
2024
Q3 		$242K Buy
2,892
+25
+0.9% +$1.97K 0.01% 778
2024
Q2 		$221K Buy
+2,867
New +$210K 0.01% 760
2021
Q2 		– Sell
-354
Closed -$14K – 721
2021
Q1 		$14K Buy
+354
New +$13.4K ﹤0.01% 1333
2020
Q2 		– Sell
-114
Closed -$4K – 445
2020
Q1 		$4K Buy
114
+31
+37% +$1.21K ﹤0.01% 1141
2019
Q4 		$4K Hold
83
– – ﹤0.01% 1130
2019
Q3 		$3K Hold
83
– – ﹤0.01% 1135
2019
Q2 		$4K Hold
83
– – ﹤0.01% 1086
2019
Q1 		$3K Hold
83
– – ﹤0.01% 1030
2018
Q4 		$3K Hold
83
– – ﹤0.01% 1013
2018
Q3 		$3K Hold
83
– – ﹤0.01% 1060
2018
Q2 		$3K Hold
83
– – ﹤0.01% 1048
2018
Q1 		$2K Hold
83
– – ﹤0.01% 948
2017
Q4 		$2K Hold
83
– – ﹤0.01% 909
2017
Q3 		$2K Buy
+83
New +$2.29K ﹤0.01% 754

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wealthcare Advisory Partners's BSX Position: Q2 2026 in Review

Wealthcare Advisory Partners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,321 shares — an estimated $208K sold.

Wealthcare Advisory Partners first reported a position in BSX in Q3 2017 and held it in 20 quarters. The position peaked at $401K in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Wealthcare Advisory Partners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 3,321 Boston Scientific shares in Q2 2026, an estimated $208K.
  • Wealthcare Advisory Partners first reported a position in Boston Scientific in Q3 2017 and held it in 20 quarters.
  • Wealthcare Advisory Partners's Boston Scientific position peaked at $401K in Q2 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.